Reducing Health Disparities Press Releases
More than 100 organizations representing millions of patients with serious health conditions and health care professionals sent a letter to Congress expressing their strong support for the Clinical Trial Modernization Act. Introduced in the House of Representatives in May 2025 by Reps. Raul Ruiz (D-CA) and August Pfluger (R-FL), the bipartisan legislation would help remove cost and geographic barriers to patient participation in clinical trials.
Massachusetts cancer survivors and caregivers urge lawmakers to support legislation that will increase access to precision medicine and patient navigation for all communities.
Hoy se presentó en el Senado de los Estados Unidos una legislación bipartidista para ampliar el acceso a las pruebas de detección del cáncer de mama y cuello uterino. La Ley de Pruebas de Detección para que las Comunidades Reciban los Servicios Necesarios de Manera Temprana y Equitativa para el Cáncer (conocida por sus siglas en inglés, SCREENS for Cancer Act) reautorizaría el Programa Nacional de Detección Temprana de Cáncer de Mama y Cuello Uterino (NBCCEDP, por sus siglas en inglés) para los años fiscales comprendidos entre 2026 y 2030.
Hoy se presentó en la Cámara de Representantes una nueva legislación federal que facilitaría la participación en estudios clínicos de todos los pacientes con cáncer. Patrocinada por los representantes Raúl Ruiz (demócrata por California) y August Pfluger (republicano por Texas), la Ley de Modernización de Ensayos Clínicos ayudaría a eliminar los obstáculos económicos y geográficos que impiden a los pacientes participar en ensayos clínicos.
With Friday marking the end of the legislative session in Hawai’i, cancer survivors, patients, and advocates with the American Cancer Society Cancer Action Network (ACS CAN) commend the state legislature for committing to health equity by passing a bill that enables researchers to study why cancer disproportionately impacts Native Hawaiians, Pacific Islanders, and Asian Americans including Filipinos in Hawai’i.
Survivors and oncology professionals share their stories with lawmakers to underscore the importance of insurance coverage of cutting-edge biomarker testing
Insurance coverage of biomarker testing will reduce health disparities for cancer patients & improve outcomes across broad spectrum of serious disease
Lawmakers asked to reduce barriers to care and reduce prescription related costs
Los representantes Neal Dunn, M.D. (R-FL) e Yvette Clarke (D-NY) presentaron ante la Cámara Baja el proyecto de ley llamado Ley sobre las Pruebas de Antígeno Prostático Específico para Hombres en Alto Riesgo con Seguro (PSA Screening for HIM Act).
Bipartisan legislation that would remove financial barriers to prostate cancer screening was introduced today in the U.S. Senate. Sponsored by Senators John Boozman (R-AR) and Cory Booker (D-NJ), the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act would waive cost-sharing requirements such as deductibles, copayments and coinsurance, for prostate cancer screening tests for men with the highest risk of prostate cancer, including Black men and those with a family history of the disease.
